Yanan Wang

Dr. Yanan Wang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2023 in EMBO Reports
Verified
Journal Article
Closed access
XSXiaorui Sun
Xiaorui Sun
CGCongwen Gao
Congwen Gao
XXXin Xu
Xin Xu
MLMengyuan Li
Mengyuan Li
XZXinhua Zhao
Xinhua Zhao
CWChen Wu
Chen Wu

1 March 2022 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
MLMing Li
Ming Li
ZLZiming Liu
Ziming Liu
JSJia Song
Jia Song
TWTian Wang
Tian Wang
HWHongjie Wang
Hongjie Wang
JGJiguang Guo
Jiguang Guo
Colorectal cancer (CRC) is the second most deadly cancer in the whole world, with the underlying mechanisms largely indistinct. Therefore, we aimed to identify significant pathways and genes involved in the initiation, formation and poor prognosis of CRC using bioinformatics methods. In this study, we compared gene expression profiles of CRC cases with those from normal colorectal tissues from three chip datasets (GSE33113, GSE23878 and GSE41328) to identify 105 differentially expressed genes (DEGs) that were common to the three datasets. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses showed that the highest proportion of up-regulated DEGs was involved in extracellular region and cytokine-cytokine receptor interaction pathways. Integral components of membrane and bile secretion pathways were identified as containing down-regulated DEGs. 13 hub DEGs were chosen and their expression were further validated by GEPIA. Only four DEGs (ADH1C, CLCA4, CXCL8 and GUCA2A) were associated with a significantly lower overall survival after the prognosis analysis. Lower ADH1C protein level and higher CXCL8 protein level were verified by immunohistochemical staining and western blot in clinical CRC and normal colorectal tissues. In conclusion, our study indicated that the extracellular tumor microenvironment and bile metabolism pathways play critical roles in the formation and progression of CRC. Furthermore, we confirmed ADH1C being down-regulated in CRC and reported ADH1C as a prognostic predictor for the first time.

7 April 2025 in BMC Urology
Verified
Journal Article
Open access
PDF file
PZPei Zhang
Pei Zhang
MLMingkai Liu
Mingkai Liu
SZShun Zhang
Shun Zhang
CLCuijuan Lu
Cuijuan Lu
QZQianhe Zu
Qianhe Zu
CBChunyan Bu
Chunyan Bu
Bladder cancer is a common malignant tumor of the urinary tract as well as one of the most common cancers worldwide. Therefore, the study of key molecular targets involved in bladder carcinogenesis and progression is crucial for the prognosis of bladder cancer. Our study aims to investigate the mechanism by which cytokeratin 17 induces epithelial-mesenchymal transition and promotes bladder cancer progression. In this study, 78 bladder cancer tissue specimens were collected, the expression level of cytokeratin 17 (CK17) in bladder cancer and paracancerous tissues was detected by immunohistochemistry, and the relationship between the CK17 expression level and the prognosis of the patients was analyzed via follow-up visits. Western Blot was performed to detect the expression level of CK17 in common bladder cancer cell lines, and the CK17-silenced and overexpressed cell lines were constructed from the selected T24 cell line with high expression of CK17 and 5637 cell line with low expression of CK17. The effects of CK17 on the proliferation, migration and invasion abilities of bladder cancer cells were evaluated by flow cytometry, Cell Counting Kit-8 (CCK-8) assay, Trans-well assay, and scratch assay. The effect of CK17 on epithelial-mesenchymal transition (EMT) markers was further detected by Western Blot and immunofluorescence, and the phosphorylation levels of AKT Ser473 and Thr308 were detected by Western Blot. In the clinical samples, CK17 expression was significantly up-regulated in cancer tissues compared with paracancerous tissues, and high levels of CK17 indicated shortened progression free survival and predicted a poorer clinical prognosis. By analyzing the relationship between CK17 and clinicopathological features, we found that the CK17 expression level was correlated with bladder cancer grade and TNM stage. Overexpression of CK17 promoted the proliferation, migration and invasion abilities of bladder cancer cells 5637, and silencing of CK17 inhibited the proliferation, migration and invasion abilities of bladder cancer cells T24. Further, we found that overexpression of CK17 in 5637 cells activated the AKT signaling pathway by increasing the phosphorylation level of AKT (Ser473), so as to up-regulate the expressions of the EMT mesenchymal markers vimentin, N-cadherin, and the transcription factors Slug and twist, while the opposite results were obtained by silencing CK17 in T24 cells. We found that high expression of CK17 promoted the proliferation, migration and invasion of bladder cancer cells and induced EMT through AKT-Ser473 phosphorylation. These findings suggest that CK17 is significantly associated with malignant progression and poor prognosis of bladder cancer patients, and it may become a new biological target for bladder cancer treatment.

1 August 2025 in Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
PDF file
BYBingna Yan
Bingna Yan
PZPei Zhang
Pei Zhang
QZQianhe Zu
Qianhe Zu
SLShan Liu
Shan Liu
PWPan Wang
Pan Wang
ZHZhe Han
Zhe Han
Background: Gastric cancer (GC) remains a major clinical challenge due to its high mortality and propensity for immune escape, which critically limits the efficacy of immunotherapy. The immunosuppressive tumor microenvironment (TME) is a key factor restricting the effectiveness of immune checkpoint inhibitors (ICIs) in GC. The nuclear factor kappa B (NF-κB) activating protein (NKAP), a conserved regulator of the NF-κB pathway, has been shown to drive immune evasion in other cancer types by modulating cytokine networks and immune cell functions. However, the specific role and mechanisms of NKAP in shaping the immunosuppressive TME of GC and contributing to resistance against programmed death ligand 1 (PD-L1) blockade therapy remain largely unexplored. Therefore, this study aimed to investigate the role of NKAP in the GC TME and elucidate its mechanisms in driving immune escape and resistance to anti-PD-L1 therapy. Methods: We analyzed datasets from The Cancer Genome Atlas (TCGA) datasets and clinical specimens from patients with GC who received neoadjuvant therapy with PD-L1 inhibitors to evaluate NKAP expression and its association with clinicopathological features. In vitro models of mature dendritic cells (mDCs) and murine xenografts were used to investigate the mechanism underlying NKAP’s involvement. NF-κB pathway activation, interleukin-10 (IL-10) secretion, and regulatory T cell (Treg) differentiation were assessed via luciferase assays, enzyme-linked immunosorbent assay, and flow cytometry. Changes in the TME and the therapeutic efficacy of PD-L1 blockade were evaluated in xenograft models. Results: Elevated NKAP expression correlated with advanced tumor-node-metastasis (TNM) stage, lymph node metastasis, and poor tumor differentiation in patients with GC. High NKAP levels predicted higher residual tumor burden post-PD-L1 therapy. Mechanistically, NKAP overexpression activated the NF-κB pathway in mDCs, driving IL-10 secretion and promoting naïve T-cell differentiation into immunosuppressive Tregs. This process fostered an immunosuppressive TME, which diminished the efficacy of PD-L1 blockade in murine models. Conclusions: NKAP is a critical regulator of GC immune escape, linking NF-κB–driven IL-10 production in mDCs to Treg-mediated immunosuppression during anti–PD-L1 therapy. Targeting NKAP may reverse resistance to ICIs, offering a promising strategy for improving clinical outcomes in patients with GC.

4 June 2024 in Pathology - Research and Practice
Verified
Journal Article
Open access
CLCuijuan Lu
Cuijuan Lu
XFXiangyu Fan
Xiangyu Fan
MZMinying Zheng
Minying Zheng
SZShun Zhang
Shun Zhang
PWPan Wang
Pan Wang
SZShiwu Zhang
Shiwu Zhang
To investigate the association between Helicobacter pylori infection and GDF6 expression in gastric cancer patients, and to determine its influence on prognosis and resistance to capecitabine. Tumor and adjacent non-tumor tissues were collected from 148 gastric cancer patients who underwent surgery in our department from October 2019 to June 2022. Of these patients, 78 tested positive for Helicobacter pylori and 70 tested negative. Hematoxylin-eosin (HE) and immunofluorescence staining were utilized to quantify GDF6 expression in cancerous and adjacent tissues. Patient prognosis was monitored via follow-up. Western blotting analyzed GDF6 expression in common gastric cancer cell lines. HGC27 cells exhibiting high GDF6 expression and BGC823 cells with low expression were used to create GDF6-silenced and overexpressed cell lines. The impact of GDF6 on the proliferation, migration, invasion, and cloning abilities of gastric cancer cells was evaluated using the CCK-8 assay, scratch test, Transwell assay, and plate colony formation assay. Fluorescent quantitative PCR and Western blotting assessed the effects of GDF6 levels on epithelial-mesenchymal transition (EMT) and tumor cell stemness. GDF6 expression in gastric cancer tissues was significantly correlated with cancer grading and staging (P<0.05). Helicobacter pylori-positive tissues exhibited significantly higher GDF6 expression levels than negative samples (P<0.05). Kaplan-Meier survival analysis indicated that high GDF6 expression was associated with poor survival prognosis. Overexpressed GDF6 enhanced the proliferation, migration, and invasion abilities of gastric cancer cells, while silencing GDF6 yielded opposite results. Increased GDF6 expression upregulated TGF-β expression and the phosphorylation levels of SMAD3, leading to an elevation in mesenchymal cell markers N-cadherin, vimentin, and a reduction in epithelial cell markers cytokeratins, E-cadherin. Moreover, high GDF6 levels contributed to increased resistance to capecitabine and enhanced the expression of tumor stem cell markers Nanog, Sox-2, Oct-4, CD44, amplifying tumor cell stemness. Helicobacter pylori infection is associated with increased GDF6 expression in gastric cancer tissue, correlating with poor survival prognosis. Elevated GDF6 expression promotes the proliferation, migration, and invasion abilities of gastric cancer cells, facilitates EMT via the TGF-β/SMAD3 pathway, and intensifies cell stemness and capecitabine resistance. Consequently, GDF6 presents itself as a potential new target for gastric cancer treatment. The data that support the findings of this study are available from the corresponding author upon reasonable request.

15 April 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
YWYanan Wang
Yanan Wang
YWYa-Ning Wei
Ya-Ning Wei
XFXiang-Yu Fan
Xiang-Yu Fan
FXFang Xu
Fang Xu
ZDZheng-Yang Dong
Zheng-Yang Dong
JZJin-Ku Zhang
Jin-Ku Zhang
Background. The specific role and prognostic value of DNA repair and replication-associated miRNAs in gastric cancer (GC) have not been clearly elucidated. Therefore, comprehensive analysis of miRNAs in GC is crucial for proposing therapeutic strategies and survival prediction. Methods. Firstly, clinical information and transcriptome data of TCGA-GC were downloaded from the database. In the entire cohort, we performed differential analysis in all miRNAs and support vector machine (SVM) was used to eliminate redundant miRNAs. Subsequently, we combined survival data and cox regression analysis to construct a miRNA signature in the training cohort. In addition, we used PCA, Kaplan-Meier, and ROC analysis to explore the prognosis value of risk score in the training and testing cohort. It is worth noting that multiple algorithms were used to evaluate difference of immune microenvironment (TME), microsatellite instability (MSI), tumor mutational burden (TMB), and immunotherapy in different risk groups. Finally, we investigated the potential mechanism about miRNA signature. Results. We constructed miRNA signature based on the following 4 miRNAs: hsa-miR-139-5p, hsa-miR-139-3p, hsa-miR-146b-5p, and hsa-miR-181a-3p. Univariate and multivariate Cox regression analyses suggested that risk score is a risk factor and an independent prognostic factor in GC patients. The AUC value of ROC analysis showed a robust prediction accuracy in each cohort. Moreover, significant differences in immune functions, immune cell content, immune checkpoint, MSI status, and TMB score were excavated in different groups distinguished by risk score. Finally, based on the above four miRNA target genes, we revealed that the signature was enriched in DNA repair and replication. Conclusion. We have developed a robust risk-formula based on 4 miRNAs that provides accurate risk stratification and prognostic prediction for GC patients. In addition, different risk subgroups may potentially guide the choice of targeted therapy.